Search

everythinglearnresearchcommunity

for

Search:↓

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

COVID-19 can cause skin issues like rashes and hair loss, which may last even after recovery.

Women with PCOS may have a higher risk of severe COVID-19 due to hormonal imbalances and vitamin D deficiency.

Photobiomodulation helps reduce pain, lessen inflammation, heal wounds, and can be used in skin treatments. It also boosts hair growth in women with hair loss and may help fight microbes and prevent respiratory issues in COVID-19.

The model successfully predicted new uses for existing drugs, like using certain hormonal and heart medications for respiratory and Parkinson's diseases, and a cancer drug for diabetes.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.

Skin symptoms could help in early COVID-19 diagnosis but more research is needed to confirm their reliability.

Hansraj is effective for various health issues but should not be used during pregnancy.

The boy's hair loss was caused by the tuberculosis drug isoniazid but grew back after stopping the medication.

Long COVID recovery is hindered by smoking, with hair loss being a difficult symptom to treat.

A 36-year-old woman with low potassium levels was found to have Cushing disease, and after treatment, her potassium levels normalized.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Almost half of COVID-19 patients in Makkah, Saudi Arabia experienced increased hair loss, especially women and those with chronic diseases.

Proper care and diet are crucial to prevent health issues in gerbils.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

High-dose vitamin D3 does not improve symptoms or quality of life in COVID-19 patients after one year.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Fresh plasma transfusions did not help treat Leiner disease in an infant.

Paclitaxel and nab-paclitaxel can be safe and effective for advanced gastric cancer patients on hemodialysis.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

Anthrax bacteria can infect and destroy hair follicles in mice, but the immune system eventually clears the infection.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

The document concludes that more research is needed to understand airway repair and to improve tissue engineering for lung treatments.

Nicotiana tabacum has potential therapeutic uses but also poses toxic risks.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

Acorus calamus has potential health benefits but needs more safety research.

A woman's hair grew back with baricitinib treatment, but she developed a temporary hairy tongue that was treated with regular tongue brushing.